Accueil
Marchés
Graphique & Idées
Algo
Nouvelles
Store
Courtiers
Télécharger
Calendrier Economique
Signaux de trading
Terminal Web
Tapez
/
pour rechercher : @user, $symbol
Recherche
Se connecter
Créer un compte
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
TGTX
#1199
TG Therapeutics, Inc.
30.0
9
-0.36%
Secteur:
Base:
Devise de Profit:
Range quotidien
Range Annuel
Changement quotidien
-0.36%
Changement Mensuel
-2.37%
Evolution sur 6 mois
+5.28%
Changement Annuel
+6.33%
Clôture Précédente
30.2
0
Open
30.0
9
Bid
Ask
Low
30.0
9
High
30.0
9
Volume
136
Marchés
Actions des Marchés US
Soins de Santé
TGTX
Open full chart
Financials
Overview
Relevé
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
155.67 M
157.07 M
158.76 M
158.67 M
158.76 M
—
Valuation ratios
Enterprise value
3.45 B
4.55 B
6.13 B
5.58 B
5.66 B
21.92 B
Price to earnings ratio
206.57
200.67
157.72
94.71
12.95
466.05
Price to sales ratio
13.3
14.67
16.12
12.81
11
54.61
Price to cash flow ratio
127.72
119.11
105.32
98.15
83.35
405.93
Price to book ratio
5.09
21.7
7.49
6.27
4.36
39.82
Enterprise value to EBITDA ratio
-8 444.09
108.29
102.35
64.98
55.06
330.68
Profitability ratios
Return on assets %
0.01
0
0.01
0.04
0.38
0.43
Return on equity %
0.02
0.01
0.02
0.1
0.64
0.78
Return on invested capital %
38.64
12.57
14.03
47.45
-294.65
-220.6
Gross margin %
88.86
85.77
87.14
86.58
82.63
342.12
Operating margin %
14.82
10.55
7.13
24.69
18.16
60.52
EBITDA margin %
14.84
27.69
7.14
24.69
18.17
77.7
Net margin %
4.63
1.77
4.19
19.97
241.73
267.66
Liquidity ratios
Quick ratio
3.91
5.03
3.04
2.96
2.89
13.91
Current ratio
4.59
6.25
4.02
3.86
3.82
17.96
Inventory turnover
0.11
0.16
0.12
0.12
0.19
0.58
Asset turnover
0.17
0.19
0.2
0.21
0.19
0.78
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
0.42
0.42
0.37
0.35
0.24
1.38
Long term debt to total equity ratio
1.27
1.1
1.03
0.89
0.4
3.42
Per share metrics
Operating cash flow per share
0.08
0.16
0.18
-0.05
0.14
0.43
EBIT per share
0.08
0.19
0.05
0.21
0.18
0.64
EBITDA per share
0.08
0.19
0.05
0.21
0.18
0.64
Total debt per share
—
—
—
—
—
—
Cash per share
2.12
1.94
1.7
1.72
1.11
6.46
Net current asset value per share
3.57
3.53
3.96
4.08
3.73
15.3
Tangible book value per share
1.2
1.39
1.46
1.7
3.77
8.32
Working capital per share
2.79
2.97
2.98
3.03
2.75
11.72
Book value per share
1.2
1.39
1.46
1.7
3.77
8.32
Nouvelles
TGTX Q4 Earnings Lag Estimates, Briumvi Sales Drive Top Line
TG Therapeutics (TGTX) Misses Q4 Earnings Estimates
TG earnings missed by $0.23, revenue topped estimates
Geron (GERN) Reports Q4 Loss, Misses Revenue Estimates
TG Therapeutics faces earnings test as Briumvi growth accelerates
TG Therapeutics (TGTX) Earnings Expected to Grow: What to Know Ahead of Q4 Release
TG Therapeutics presents BRIUMVI data at ACTRIMS forum
TG Therapeutics stock maintains Buy rating at B.Riley on strong Briumvi growth
TG Therapeutics to present BRIUMVI data at ACTRIMS forum
Genmab: Darzalex Growth Fuels Rally, Upside Is Tight (NASDAQ: GMAB)
TG Therapeutics stock holds Overweight rating at Cantor Fitzgerald
TG Therapeutics Stock Rises 7% on Strong Q4 & 2025 Preliminary Results